1. Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137?195
2. Chiodini I, Carnevale V, Torlontano M, Fusilli S, Guglielmi G, Pileri M, Modoni S, Di Giorgio A, Liuzzi A, Minisola S, Cammisa M, Trischitta V, Scillitani A (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing?s syndrome. J Clin Endocrinol Metab 83:1863?1867
3. Godang K, Ueland T, Bollerslev J (1999) Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing?s syndrome. Eur J Endocrinol 141:126?31
4. Osella G, Terzolo M, Reimondo A (1997) Serum markers of bone and collagen turnover in patients with Cushing?s syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 82:3303?3307
5. Kimberg DV, Baerg RD, Gershon E, Graudusius RT (1971) Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 50:1309?1321